No joke - CCR5 is a novel target for the treatment
Post# of 148282
(Total Views: 701)
Posted On: 12/02/2020 1:52:12 PM
Re: FIREwithCYDY #66768
No joke - CCR5 is a novel target for the treatment of experimental alopecia areata
https://onlinelibrary.wiley.com/doi/full/10.1002/cia2.12092
I can imagine in the not too distant future, a cable channel that runs 24/7/365 infomercials for all the different conditions that Leronlimab can treat. Each with their own "trade name":
Hair loss = VillusLogix
Libido enhancer = ViriliLogix
Cogitative enhancer = SciensLogix (I fixed this one)
...
When they get to the usual disclaimer part where they have to speed up the commentator's voice track to get in all the thousands of side-effects or contraindications ...they just say...."Nada".
https://onlinelibrary.wiley.com/doi/full/10.1002/cia2.12092
I can imagine in the not too distant future, a cable channel that runs 24/7/365 infomercials for all the different conditions that Leronlimab can treat. Each with their own "trade name":
Hair loss = VillusLogix
Libido enhancer = ViriliLogix
Cogitative enhancer = SciensLogix (I fixed this one)
...
When they get to the usual disclaimer part where they have to speed up the commentator's voice track to get in all the thousands of side-effects or contraindications ...they just say...."Nada".
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼